View More Recent Stories

Mar 25, 2025 04:00PM MRVI INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Maravai LifeSciences Holdings, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

Mar 25, 2025 03:23PM ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Maravai Lifesciences Holdings, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - MRVI

Mar 24, 2025 03:17PM ROSEN, A TOP RANKED LAW FIRM, Encourages Maravai Lifesciences Holdings, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - MRVI

Mar 23, 2025 11:00AM ROSEN, A LEADING LAW FIRM, Encourages Maravai Lifesciences Holdings, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - MRVI

Mar 22, 2025 10:42AM ROSEN, A LEADING LAW FIRM, Encourages Maravai Lifesciences Holdings, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - MRVI

Mar 21, 2025 10:24AM Maravai LifeScience Holdings Inc. (MRVI) PT Lowered to $5 at Stifel

Mar 20, 2025 04:29PM Maravai LifeSciences Holdings, Inc. (MRVI) Faces Securities Class Action After Delaying Q4 and FY 2024 Earnings Release, Admitting to Improper Revenue Recognition - Hagens Berman

Mar 19, 2025 05:42PM ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Maravai Lifesciences Holdings, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - MRVI

Mar 19, 2025 04:00PM MRVI INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Maravai LifeSciences Holdings, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

Mar 19, 2025 09:46AM Increasing unusual option volume: MRVI ZTO OLLI SIG SRPT WSM STNE IMVT OI

Mar 18, 2025 07:43PM SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Maravai LifeSciences

Mar 18, 2025 04:08PM Maravai LifeSciences (MRVI) Misses Q4 EPS by 2c

Mar 18, 2025 02:10PM ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Maravai Lifesciences Holdings, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - MRVI

Mar 18, 2025 07:20AM MRVI INVESTOR ALERT: Maravai LifeSciences Holdings, Inc. Investors with Substantial Losses Have Opportunity to Lead Investor Class Action Lawsuit

Mar 16, 2025 01:46PM ROSEN, LEADING INVESTOR COUNSEL, Encourages Maravai Lifesciences Holdings, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - MRVI

Mar 15, 2025 01:46PM ROSEN, A TOP RANKED LAW FIRM, Encourages Maravai Lifesciences Holdings, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - MRVI

Mar 14, 2025 11:40AM Maravai LifeSciences Holdings, Inc. (MRVI) Faces Securities Class Action After Delaying Q4 and FY 2024 Earnings Release, Admitting to Improper Revenue Recognition - Hagens Berman

Mar 13, 2025 04:00PM MRVI INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Maravai LifeSciences Holdings, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

Mar 12, 2025 05:48PM Faruqi & Faruqi Reminds Maravai LifeSciences Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of May 5, 2025 - MRVI

Mar 11, 2025 07:45PM ROSEN, LEADING TRIAL ATTORNEYS, Encourages Maravai Lifesciences Holdings, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - MRVI

Mar 10, 2025 02:44PM ROSEN, TOP-RANKED INVESTOR COUNSEL, Encourages Maravai Lifesciences Holdings, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - MRVI

Mar 9, 2025 11:15AM MRVI INVESTOR NOTICE: Maravai LifeSciences Holdings, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

Mar 7, 2025 04:00PM MRVI INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Maravai LifeSciences Holdings, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

Feb 26, 2025 10:29AM Stock Alert: Maravai LifeSciences Holdings - Company Will Delay Earnings Release - Kehoe Law Firm, P.C. Investigating Potential Securities Claims - MRVI

Feb 26, 2025 03:39AM Baird Downgrades Maravai LifeScience Holdings Inc. (MRVI) to Neutral

Feb 25, 2025 08:43AM Maravai LifeSciences (MRVI) Postpones its Fourth Quarter and Full Year 2024 Earnings Release and Conference Call

Jan 28, 2025 04:01PM Maravai LifeSciences (MRVI) Acquires Assets and Intellectual Property from Molecular Assemblies

Jan 8, 2025 04:12PM Maravai LifeSciences (MRVI) Announces In-Line Preliminary 2024 Revenue

Dec 19, 2024 07:25AM Guggenheim Starts Maravai LifeScience Holdings Inc. (MRVI) at Neutral

Dec 5, 2024 04:13AM Goldman Sachs Downgrades Maravai LifeScience Holdings Inc. (MRVI ) to Sell

Nov 14, 2024 06:03AM Wolfe Research Starts Maravai LifeScience Holdings Inc. (MRVI) at Peerperform

Nov 7, 2024 04:27PM Maravai LifeSciences (MRVI) Misses Q3 EPS by 1c, provides guidance

Nov 7, 2024 04:01PM Maravai LifeSciences (MRVI) to Acquire DNA and RNA Business of Officinae Bio

Aug 28, 2024 07:54AM Cygnus Technologies and TriLink BioTechnologies® Collaborate to Launch AccuRes Host Cell DNA Quantification Kits (MRVI)

Aug 19, 2024 07:47AM KeyBanc Reiterates Overweight Rating on Repligen (RGEN)

Aug 16, 2024 02:53PM Stifel on Repligen (RGEN) M&A Speculation with Maravai (MRVI)

Aug 16, 2024 12:00PM Midday movers: H&R Block, Maravai LifeSciences rise; Applied Materials falls

Aug 16, 2024 11:40AM Repligen (RGEN) Has Approached Maravai Lifesciences (MRVI) with an Acquisition Offer - Reuters

Aug 16, 2024 11:39AM Maravai LifeSciences (MRVI) Halted on Circuit Breaker Up 11%

Aug 13, 2024 03:36AM Morgan Stanley Downgrades Maravai LifeScience Holdings Inc. (MRVI) to Equalweight

Aug 7, 2024 05:30PM Maravai LifeSciences (MRVI) Misses Q2 EPS by 5c, provides guidance

Jul 29, 2024 04:19PM Maravai LifeSciences (MRVI) Appoints Trey Martin to Board of Directors

Jun 20, 2024 09:18AM Applied DNA Sciences (APDN) and Alphazyme (MRVI) Conclude Linea RNAP Manufacturing Scale-up Project

Jun 20, 2024 09:15AM Applied DNA and Alphazyme Conclude Linea(TM) RNAP Manufacturing Scale-up Project, Deliver Substantial Improvement in Linea(TM) IVT Platform Economics

View More Recent Stories